Brief: Bioservo Technologies Q4 EBITDA Loss Narrows To SEK 4.0 Million

Bioservo Technologies AB

19/02/2019 07:42

Feb 19 (Reuters) - Bioservo Technologies AB  BIOSE.ST :
    * Q4 NET SALES SEK 2.8 MILLION VERSUS SEK 2.6 MILLION YEAR
AGO
    * PROPOSES THAT NO DIVIDEND BE PAID
    * Q4 EBITDA LOSS SEK 4.0 MILLION VERSUS LOSS SEK 5.0 MILLION
YEAR
AGO
    * BIOSERVO TECHNOLOGIES - NEXT VERSION OF IRONHAND IS
EXPECTED TO
BE READY FOR MARKET AT END OF Q2 OF 2019
    * BIOSERVO TECHNOLOGIES- IS PREPARING CLINICAL TRIALS FOR
CARBONHAND, WHICH WILL START DURING H1 2019

Source text for Eikon:  ID:nWkr3RbgQ0 
Further company coverage:  BIOSE.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))